WH
WuXi Healthcare Ventures
Cambridge, Massachusetts, United StatesFounded 2011
WuXi Healthcare Ventures was a cross-border venture capital firm that focused on early-stage opportunities in the life sciences and healthcare sectors, particularly in therapeutic, platform technology, and diagnostic companies. Its primary strategy was "find in U.S. and build in China," emphasizing investments in both the United States and China.
86% of their portfolio is in Biotech & Life Sciences. Their most common stage is series-b (57% of deals). Average disclosed round size is $88.6M (across 7 rounds with reported amounts).
Portfolio
7
Fund Size
$350M
Top Stage
Series B
Last 12 Mo
0
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
7 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| CCStone Pharmaceuticals | Series B | $260M | May 2018 |
 Refuge Biotechnologies, Inc. | Series B | $25M | May 2018 |
 IDEAYA Biosciences | Series B | $94M | Mar 2018 |
 LifeMine Therapeutics | Series A | $55M | Sep 2017 |
 Vivace Therapeutics, Inc. | Series B | $25M | Jun 2017 |
| IDEAYA Biosciences | Series A | $46M | May 2016 |
 23andMe | Series E | $115M | Oct 2015 |
Top Co-Investors
Sequoia China3 shared
Canaan Partners3 shared
GV (Google Ventures)2 shared
ARCH Venture Partners2 shared
Boyu Capital2 shared
Alexandria Venture Investments2 shared
NEA (New Enterprise Associates)1 shared
Casdin Capital1 shared
Danhua Capital1 shared
3E Bioventures Capital1 shared
ShangBay Capital1 shared
Foresite Capital1 shared
Blue Pool Capital1 shared
MRL Ventures Fund1 shared
Perceptive Advisors1 shared
Roche Venture Fund1 shared
Yunfeng Capital1 shared
Hillhouse Capital1 shared
Celgene1 shared
Last updated: 16 April 2026